A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
Clinical trial NCT07614984 · RECRUITING
Trial details
- NCT number
- NCT07614984
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2027-10-12
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.